# PharmaCyte Biotech, Inc.: Form 10-Q/A for the period ended Jul 31, 2011

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 10-Q/A
- Filed: 2011-09-20
- Accepted by EDGAR: Sep 20, 2011, 16:37 ET
- Period: 2011-07-31
- Accession: 0001262463-11-000192
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000126246311000192/nvlx_2qa7312011.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000126246311000192/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2011-07-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2011-05-01 to 2011-07-31 | $19.8k | us-gaap:Revenues |
| Cost of revenue | 3 months, 2011-05-01 to 2011-07-31 | $15.7k | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2011-05-01 to 2011-07-31 | $4.1k | us-gaap:GrossProfit |
| Interest expense | 3 months, 2011-05-01 to 2011-07-31 | −$33.4k | us-gaap:InterestExpense |
| Net income | 3 months, 2011-05-01 to 2011-07-31 | −$686.0k | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months, 2011-05-01 to 2011-07-31 | $0.00 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 3 months, 2011-05-01 to 2011-07-31 | −$119.6k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2011-07-31 | $83.1k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2011-07-31 | $449.2k | us-gaap:AssetsCurrent |
| Total assets | at 2011-07-31 | $1.6m | us-gaap:Assets |
| Current liabilities | at 2011-07-31 | $3.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2011-07-31 | $3.4m | us-gaap:Liabilities |
| Short-term borrowings | at 2011-07-31 | $2.4m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2011-07-31 | −$2.4m | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000126246311000192/nvlx_2qa7312011.htm

Filed Sep 20, 2011.
Source: SEC EDGAR, the filing index for accession 0001262463-11-000192. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
